Epalrestat suppresses cadmium-induced cytotoxicity through Nrf2 in endothelial cells

  • Authors:
    • Ryosuke Tatsunami
    • Keisuke Sato
    • Yu Murao
    • Kaori Yama
    • Yang Yu
    • Shun Ohno
    • Yoshiko Tampo
  • View Affiliations

  • Published online on: February 24, 2021     https://doi.org/10.3892/etm.2021.9824
  • Article Number: 393
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cadmium (Cd) is an industrial and environmental pollutant that targets the vascular endothelium. The vascular system is critically affected by Cd toxicity. Recent studies have indicated an association between Cd and vascular diseases, although the mechanisms of Cd implications in vascular diseases are not clear. The purpose of the present study was to determine whether epalrestat (EPS), which is used for the treatment of diabetic neuropathy, protects against Cd-induced cytotoxicity in bovine aortic endothelial cells (BAECs). In the present study, the effects of EPS at near-plasma concentration were examined on Cd-induced cytotoxicity in BAECs. Cd-induced cytotoxicity was suppressed by pretreatment with EPS. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor that serves a role in regulating the expression of glutamate cysteine ligase, the rate-limiting enzyme in glutathione (GSH) synthesis. In a previous study, EPS was demonstrated to increase GSH levels in BAECs in association with the Nrf2 pathway. In the present study, EPS increased GSH levels in BAECs exposed to Cd. The protective ability of EPS against the Cd-induced cytotoxicity disappeared following Nrf2 small interfering RNA transfection. In addition, EPS affected the intracellular levels of Cd, Cd transporter ZIP8 and metallothionein. To the best of our knowledge, the current study demonstrated, for the first time, that EPS suppresses Cd-induced cytotoxicity in BAECs. The upregulation of GSH may be associated with the suppression of Cd-induced cytotoxicity by EPS. From these findings, it may be proposed that the regulation of GSH, ZIP8 and metallothionein by EPS is a promising therapeutic approach to prevent Cd-induced toxicity.
View Figures
View References

Related Articles

Journal Cover

April-2021
Volume 21 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tatsunami R, Sato K, Murao Y, Yama K, Yu Y, Ohno S and Tampo Y: Epalrestat suppresses cadmium-induced cytotoxicity through Nrf2 in endothelial cells. Exp Ther Med 21: 393, 2021
APA
Tatsunami, R., Sato, K., Murao, Y., Yama, K., Yu, Y., Ohno, S., & Tampo, Y. (2021). Epalrestat suppresses cadmium-induced cytotoxicity through Nrf2 in endothelial cells. Experimental and Therapeutic Medicine, 21, 393. https://doi.org/10.3892/etm.2021.9824
MLA
Tatsunami, R., Sato, K., Murao, Y., Yama, K., Yu, Y., Ohno, S., Tampo, Y."Epalrestat suppresses cadmium-induced cytotoxicity through Nrf2 in endothelial cells". Experimental and Therapeutic Medicine 21.4 (2021): 393.
Chicago
Tatsunami, R., Sato, K., Murao, Y., Yama, K., Yu, Y., Ohno, S., Tampo, Y."Epalrestat suppresses cadmium-induced cytotoxicity through Nrf2 in endothelial cells". Experimental and Therapeutic Medicine 21, no. 4 (2021): 393. https://doi.org/10.3892/etm.2021.9824